Cargando…
SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac
PURPOSE/OBJECTIVES: This work seeks to evaluate the plan quality, treatment delivery efficiency, and accuracy of single‐isocenter volumetric modulated arc therapy (VMAT) of abdominal/pelvic oligometastatic lymph nodes (LNs) stereotactic body radiation therapy (SBRT) on Halcyon Linac. MATERIALS AND M...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200515/ https://www.ncbi.nlm.nih.gov/pubmed/34032367 http://dx.doi.org/10.1002/acm2.13268 |
_version_ | 1783707621347295232 |
---|---|
author | Pokhrel, Damodar Webster, Aaron Stephen, Joseph St Clair, William |
author_facet | Pokhrel, Damodar Webster, Aaron Stephen, Joseph St Clair, William |
author_sort | Pokhrel, Damodar |
collection | PubMed |
description | PURPOSE/OBJECTIVES: This work seeks to evaluate the plan quality, treatment delivery efficiency, and accuracy of single‐isocenter volumetric modulated arc therapy (VMAT) of abdominal/pelvic oligometastatic lymph nodes (LNs) stereotactic body radiation therapy (SBRT) on Halcyon Linac. MATERIALS AND METHODS: After completing the in‐house multitarget end‐to‐end phantom testing and independent dose verification using MD Anderson’s single‐isocenter/multi‐target (lung and spine target inserts) thorax phantom, eight patients with two to three abdominal/pelvic oligometastatic LNs underwent highly conformal single‐isocenter VMAT‐SBRT treatment using the Halcyon Linac 6MV flattening filter free (FFF) beam. Targets were identified using an Axumin PET/CT scan co‐registered with planning CT images and a single‐isocenter was placed between/among the targets. Doses between 25 and 36.25 Gy in 5 fractions were delivered. Patients were treated every other day. Plans were calculated in Eclipse with advanced AcurosXB algorithm for heterogeneity corrections. For comparison, Halcyon VMAT‐SBRT plans were retrospectively generated for SBRT‐dedicated TrueBeam with a 6MV‐FFF beam using identical planning geometry and objectives. Target coverage, conformity index (CI), dose to 2 cm away from each target (D2cm) and dose to adjacent organs‐at‐risk (OAR) were evaluated. Additionally, various treatment delivery parameters including beam‐on time were recorded. RESULTS: Phantom measurements showed acceptable spatial accuracy of conebeam CT‐guided Halcyon SBRT treatments including compliance with MD Anderson’s single‐isocenter/multi‐targets phantom credentialing results. For patients, the mean isocenter to tumor center distance was 3.4 ± 1.2 cm (range, 1.5–4.8 cm). The mean combined PTV was 18.9 ± 10.9 cc (range, 5.6–39.5 cc). There was no clinically significant difference in dose to LNs, CI, D2cm and maximal doses to OAR between single‐isocenter Halcyon and Truebeam VMAT‐SBRT plans, although, Halcyon plans provided preferably lower maximal dose to adjacent OAR. Additionally, total monitor units, beam‐on time and overall treatment time was lower with Halcyon plans. Halcyon’s portal dosimetry demonstrated a high pass rate of 98.1 ± 1.6% for clinical gamma passing criteria of 2%/2 mm. CONCLUSION: SBRT treatment of abdominal/pelvic oligometastatic LNs with single‐isocenter VMAT on Halcyon was dosimetrically equivalent to TrueBeam. Faster treatment delivery to oligometastatic LNs via single‐isocenter Halcyon VMAT can improve clinic workflow and patient compliance, potentially reducing intrafraction motion errors for well‐suited patients. Clinical follow‐up of these patients is ongoing. |
format | Online Article Text |
id | pubmed-8200515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82005152021-06-15 SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac Pokhrel, Damodar Webster, Aaron Stephen, Joseph St Clair, William J Appl Clin Med Phys Radiation Oncology Physics PURPOSE/OBJECTIVES: This work seeks to evaluate the plan quality, treatment delivery efficiency, and accuracy of single‐isocenter volumetric modulated arc therapy (VMAT) of abdominal/pelvic oligometastatic lymph nodes (LNs) stereotactic body radiation therapy (SBRT) on Halcyon Linac. MATERIALS AND METHODS: After completing the in‐house multitarget end‐to‐end phantom testing and independent dose verification using MD Anderson’s single‐isocenter/multi‐target (lung and spine target inserts) thorax phantom, eight patients with two to three abdominal/pelvic oligometastatic LNs underwent highly conformal single‐isocenter VMAT‐SBRT treatment using the Halcyon Linac 6MV flattening filter free (FFF) beam. Targets were identified using an Axumin PET/CT scan co‐registered with planning CT images and a single‐isocenter was placed between/among the targets. Doses between 25 and 36.25 Gy in 5 fractions were delivered. Patients were treated every other day. Plans were calculated in Eclipse with advanced AcurosXB algorithm for heterogeneity corrections. For comparison, Halcyon VMAT‐SBRT plans were retrospectively generated for SBRT‐dedicated TrueBeam with a 6MV‐FFF beam using identical planning geometry and objectives. Target coverage, conformity index (CI), dose to 2 cm away from each target (D2cm) and dose to adjacent organs‐at‐risk (OAR) were evaluated. Additionally, various treatment delivery parameters including beam‐on time were recorded. RESULTS: Phantom measurements showed acceptable spatial accuracy of conebeam CT‐guided Halcyon SBRT treatments including compliance with MD Anderson’s single‐isocenter/multi‐targets phantom credentialing results. For patients, the mean isocenter to tumor center distance was 3.4 ± 1.2 cm (range, 1.5–4.8 cm). The mean combined PTV was 18.9 ± 10.9 cc (range, 5.6–39.5 cc). There was no clinically significant difference in dose to LNs, CI, D2cm and maximal doses to OAR between single‐isocenter Halcyon and Truebeam VMAT‐SBRT plans, although, Halcyon plans provided preferably lower maximal dose to adjacent OAR. Additionally, total monitor units, beam‐on time and overall treatment time was lower with Halcyon plans. Halcyon’s portal dosimetry demonstrated a high pass rate of 98.1 ± 1.6% for clinical gamma passing criteria of 2%/2 mm. CONCLUSION: SBRT treatment of abdominal/pelvic oligometastatic LNs with single‐isocenter VMAT on Halcyon was dosimetrically equivalent to TrueBeam. Faster treatment delivery to oligometastatic LNs via single‐isocenter Halcyon VMAT can improve clinic workflow and patient compliance, potentially reducing intrafraction motion errors for well‐suited patients. Clinical follow‐up of these patients is ongoing. John Wiley and Sons Inc. 2021-05-25 /pmc/articles/PMC8200515/ /pubmed/34032367 http://dx.doi.org/10.1002/acm2.13268 Text en © 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of American Association of Physicists in Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Pokhrel, Damodar Webster, Aaron Stephen, Joseph St Clair, William SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac |
title | SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac |
title_full | SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac |
title_fullStr | SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac |
title_full_unstemmed | SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac |
title_short | SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac |
title_sort | sbrt treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted halcyon linac |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200515/ https://www.ncbi.nlm.nih.gov/pubmed/34032367 http://dx.doi.org/10.1002/acm2.13268 |
work_keys_str_mv | AT pokhreldamodar sbrttreatmentofabdominalandpelvicoligometastaticlymphnodesusingringmountedhalcyonlinac AT websteraaron sbrttreatmentofabdominalandpelvicoligometastaticlymphnodesusingringmountedhalcyonlinac AT stephenjoseph sbrttreatmentofabdominalandpelvicoligometastaticlymphnodesusingringmountedhalcyonlinac AT stclairwilliam sbrttreatmentofabdominalandpelvicoligometastaticlymphnodesusingringmountedhalcyonlinac |